Barclays Has Lowered Expectations for Mettler-Toledo International (NYSE:MTD) Stock Price

Mettler-Toledo International (NYSE:MTD) had its price target dropped by stock analysts at Barclays from $1,600.00 to $1,550.00 in a report issued on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the medical instruments supplier’s stock. Barclays‘s target price would suggest a potential upside of 9.57% from the stock’s previous close.

MTD has been the subject of a number of other research reports. Citigroup raised their price objective on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a research note on Monday, November 10th. Morgan Stanley started coverage on shares of Mettler-Toledo International in a research report on Tuesday, December 2nd. They issued an “equal weight” rating and a $1,550.00 price target for the company. Bank of America upgraded shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price target for the company in a research note on Monday. The Goldman Sachs Group initiated coverage on shares of Mettler-Toledo International in a research note on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price objective on the stock. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a report on Thursday, October 9th. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $1,441.67.

Mettler-Toledo International Stock Up 1.5%

NYSE:MTD traded up $20.93 during trading hours on Monday, reaching $1,414.57. The company had a trading volume of 72,311 shares, compared to its average volume of 163,267. The firm has a market cap of $28.90 billion, a price-to-earnings ratio of 35.28, a P/E/G ratio of 4.50 and a beta of 1.40. The business’s 50-day simple moving average is $1,402.13 and its two-hundred day simple moving average is $1,293.95. Mettler-Toledo International has a twelve month low of $946.69 and a twelve month high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, beating the consensus estimate of $10.62 by $0.53. The firm had revenue of $1.03 billion for the quarter, compared to analyst estimates of $997.36 million. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The business’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $10.21 earnings per share. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. As a group, equities analysts predict that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, insider La Guerroniere Marc De sold 6,055 shares of the business’s stock in a transaction dated Tuesday, November 25th. The shares were sold at an average price of $1,488.18, for a total value of $9,010,929.90. Following the transaction, the insider directly owned 187 shares in the company, valued at $278,289.66. The trade was a 97.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Elisha W. Finney sold 474 shares of the stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $1,433.57, for a total transaction of $679,512.18. Following the transaction, the director directly owned 311 shares of the company’s stock, valued at $445,840.27. This represents a 60.38% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 19,565 shares of company stock worth $28,683,737. Company insiders own 0.77% of the company’s stock.

Hedge Funds Weigh In On Mettler-Toledo International

Institutional investors have recently bought and sold shares of the company. Sound Income Strategies LLC boosted its holdings in shares of Mettler-Toledo International by 477.8% in the second quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock worth $61,000 after acquiring an additional 43 shares during the period. Acadian Asset Management LLC raised its stake in shares of Mettler-Toledo International by 84.9% during the 1st quarter. Acadian Asset Management LLC now owns 2,513 shares of the medical instruments supplier’s stock valued at $2,965,000 after purchasing an additional 1,154 shares during the period. Financial Advisors Network Inc. lifted its holdings in Mettler-Toledo International by 808.9% during the 1st quarter. Financial Advisors Network Inc. now owns 3,254 shares of the medical instruments supplier’s stock worth $3,843,000 after purchasing an additional 2,896 shares in the last quarter. Focus Partners Wealth boosted its stake in Mettler-Toledo International by 85.6% in the 1st quarter. Focus Partners Wealth now owns 3,195 shares of the medical instruments supplier’s stock worth $3,774,000 after purchasing an additional 1,474 shares during the period. Finally, CW Advisors LLC grew its holdings in Mettler-Toledo International by 250.3% during the 1st quarter. CW Advisors LLC now owns 620 shares of the medical instruments supplier’s stock valued at $737,000 after buying an additional 443 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.